Brief: Medtronic Gains FDA Approval For Altaviva Device To Treat Urge Urinary Incontinence
19/09/2025 13:34
Sept 19 (Reuters) - Medtronic PLC MDT.N: MEDTRONIC SECURES FDA APPROVAL FOR THE ALTAVIVA™ DEVICE, A SIMPLE EXPERIENCE FOR TREATING URGE URINARY INCONTINENCE Source text: ID:nPn5t2KfCa Further company coverage: MDT.N ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Medtronic
See all newsStreet View: Medtronic moves from 'show me' story to 'trust the setup' story
U.S. STOCKS ON THE MOVE-Medtronic, Macy's, USA Rare Earth
S&P 500 top and bottom performing stocks at about 12:00 p.m. EDT
U.S. STOCKS ON THE MOVE-USA Rare Earth, MiniMed, Rent the Runway
Medtronic climbs after Q4 results beat estimates